Adela is leading a global team of subject matter experts in export controls and sanctions and advising and guiding the Philips Export Control Officer Network around the world. She is representing Philips towards various governmental and non-governmental bodies worldwide and actively participating in export controls and sanctions regulatory and policy matters.
She is an export controls and sanctions professional with vast experience in leading operations, projects and teams in semiconductions, consumer, personal health and healthcare industry. Areas of expertise cover compliance framework management, license management, risk management, government affairs, M&A due diligence, CFIUS, encryption controls, sanctions, under EU, US and other legal jurisdictions relevant for Philips.
In 2017 Adela has been nominated and received the Award for Excellence in Export Controls – Netherlands as part of the AI 2017 Influential Businesswoman Awards.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment, and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care